Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach
Abstract Significant implications of glycogen synthase kinase-3β (GSK-3β) have been reported in various neuronal disorders and malignant cancers. GSK-3β modulates diverse protein targets through phosphorylation, and its aberrant activity leads to neurological complications as well as tumour onset. T...
Saved in:
Main Authors: | Shabir Ahmad Ganai, Suma Mohan, Shahid Ahmad Padder |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-85868-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Odontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides
by: Vidhyashree Rajasekar, et al.
Published: (2025-02-01) -
NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma
by: Chao-Yan Yao, et al.
Published: (2025-02-01) -
Electroacupuncture regulates ferroptosis to improve postoperative cognitive dysfunction in mice through mediating GRX1/GSK-3β/Nrf2 axis
by: Xiaqing Zhang, et al.
Published: (2025-03-01) -
Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
by: Mei Wang, et al.
Published: (2025-02-01) -
DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors
by: El Mehdi Karim, et al.
Published: (2025-03-01)